In contrast, GSK-3β activation decreased cell proliferation of breast cancer cells [13], prostate cancer cells [14], and colon cancer cells [15] as well as survival of prostate cancer cells [16], breast cancer cells [17], and colorectal cells [8]. The gene discussed is GSK3B; the disease is prostate carcinoma.